Literature DB >> 31430650

Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.

Cecilia S Lindestam Arlehamn1, Francesca Garretti2, David Sulzer3, Alessandro Sette4.   

Abstract

Neurodegenerative diseases, such as Parkinson's and Alzheimer's, affect millions of people and pose major personal and socioeconomic burdens. The causes of neurodegeneration are mostly unknown, although current efforts have described an autoimmune aspect to these diseases. Here we discuss recent findings that shed light on the involvement of the adaptive immune system in Parkinson's and Alzheimer's diseases, and provide a model and outlook for further investigation of T cell responses in neurodegenerative disease. We focus on the identification of T cell epitopes from proteins involved in disease pathogenesis and describe the identification of α-synuclein-specific epitopes in Parkinson's disease which provided a crucial link between disease susceptibility and T cell recognition.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31430650      PMCID: PMC6774843          DOI: 10.1016/j.coi.2019.07.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  40 in total

1.  Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease.

Authors:  E Caggiu; K Paulus; G Galleri; G Arru; R Manetti; G P Sechi; L A Sechi
Journal:  J Neuroimmunol       Date:  2017-06-15       Impact factor: 3.478

2.  Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus.

Authors:  Ben Readhead; Jean-Vianney Haure-Mirande; Cory C Funk; Matthew A Richards; Paul Shannon; Vahram Haroutunian; Mary Sano; Winnie S Liang; Noam D Beckmann; Nathan D Price; Eric M Reiman; Eric E Schadt; Michelle E Ehrlich; Sam Gandy; Joel T Dudley
Journal:  Neuron       Date:  2018-06-21       Impact factor: 17.173

Review 3.  Spreading of pathology in neurodegenerative diseases: a focus on human studies.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Neurosci       Date:  2015-01-15       Impact factor: 34.870

Review 4.  Type 1 diabetes mellitus.

Authors:  Anastasia Katsarou; Soffia Gudbjörnsdottir; Araz Rawshani; Dana Dabelea; Ezio Bonifacio; Barbara J Anderson; Laura M Jacobsen; Desmond A Schatz; Åke Lernmark
Journal:  Nat Rev Dis Primers       Date:  2017-03-30       Impact factor: 52.329

Review 5.  Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Authors:  Etienne C Hirsch; Stéphane Hunot
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 6.  Neuronal vulnerability, pathogenesis, and Parkinson's disease.

Authors:  David Sulzer; D James Surmeier
Journal:  Mov Disord       Date:  2013-04-15       Impact factor: 10.338

Review 7.  Classification and basic pathology of Alzheimer disease.

Authors:  Charles Duyckaerts; Benoît Delatour; Marie-Claude Potier
Journal:  Acta Neuropathol       Date:  2009-04-21       Impact factor: 17.088

8.  Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.

Authors:  Alon Monsonego; Victor Zota; Arnon Karni; Jeffery I Krieger; Amit Bar-Or; Gal Bitan; Andrew E Budson; Reisa Sperling; Dennis J Selkoe; Howard L Weiner
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.

Authors:  Ashley S Harms; Shuwen Cao; Amber L Rowse; Aaron D Thome; Xinru Li; Leandra R Mangieri; Randy Q Cron; John J Shacka; Chander Raman; David G Standaert
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

10.  Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.

Authors:  S Itagaki; P L McGeer; H Akiyama
Journal:  Neurosci Lett       Date:  1988-09-12       Impact factor: 3.046

View more
  17 in total

Review 1.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

2.  T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils.

Authors:  Sonia George; Trevor Tyson; Nolwen L Rey; Rachael Sheridan; Wouter Peelaerts; Katelyn Becker; Emily Schulz; Lindsay Meyerdirk; Amanda R Burmeister; Christian U von Linstow; Jennifer A Steiner; Martha L Escobar Galvis; Jiyan Ma; J Andrew Pospisilik; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 3.  Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis.

Authors:  Chaska C Walton; David Begelman; Wynnie Nguyen; Julie K Andersen
Journal:  Front Cell Neurosci       Date:  2020-05-19       Impact factor: 5.505

Review 4.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

5.  The TCR repertoire of α-synuclein-specific T cells in Parkinson's disease is surprisingly diverse.

Authors:  Akul Singhania; John Pham; Rekha Dhanwani; April Frazier; Juliana Rezende Dutra; Karen S Marder; Elizabeth Phillips; Simon Mallal; Amy W Amara; David G Standaert; David Sulzer; Bjoern Peters; Alessandro Sette; Cecilia S Lindestam Arlehamn
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

6.  Potential Tear Biomarkers for the Diagnosis of Parkinson's Disease-A Pilot Study.

Authors:  Arantxa Acera; Juan Carlos Gómez-Esteban; Ane Murueta-Goyena; Marta Galdos; Mikel Azkargorta; Felix Elortza; Noelia Ruzafa; Oliver Ibarrondo; Xandra Pereiro; Elena Vecino
Journal:  Proteomes       Date:  2022-01-13

7.  Specific immune status in Parkinson's disease at different ages of onset.

Authors:  Jun Tian; Shao-Bing Dai; Si-Si Jiang; Wen-Yi Yang; Yi-Qun Yan; Zhi-Hao Lin; Jia-Xian Dong; Yi Liu; Ran Zheng; Ying Chen; Bao-Rong Zhang; Jia-Li Pu
Journal:  NPJ Parkinsons Dis       Date:  2022-01-10

8.  Putative autoantibodies in the cerebrospinal fluid of Alzheimer's disease patients.

Authors:  Bryant Lim; Magda Tsolaki; Ihor Batruch; Anna Anastasiou; Antonis Frontistis; Ioannis Prassas; Eleftherios P Diamandis
Journal:  F1000Res       Date:  2019-11-11

Review 9.  Immunotherapy for Parkinson's disease.

Authors:  Aaron D Schwab; Mackenzie J Thurston; Jatin Machhi; Katherine E Olson; Krista L Namminga; Howard E Gendelman; R Lee Mosley
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

Review 10.  The Role of T Cell Senescence in Neurological Diseases and Its Regulation by Cellular Metabolism.

Authors:  Johannes Fessler; Stefano Angiari
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.